metformin accord 850mg potahovaná tableta
accord healthcare polska sp. z o.o., varšava array - 2418 metformin-hydrochlorid - potahovaná tableta - 850mg - metformin
metformin viatris 1000mg potahovaná tableta
viatris limited, dublin array - 2418 metformin-hydrochlorid - potahovaná tableta - 1000mg - metformin
metformin viatris 500mg potahovaná tableta
viatris limited, dublin array - 2418 metformin-hydrochlorid - potahovaná tableta - 500mg - metformin
metformin viatris 850mg potahovaná tableta
viatris limited, dublin array - 2418 metformin-hydrochlorid - potahovaná tableta - 850mg - metformin
metformin sandoz 1000mg potahovaná tableta
sandoz s.r.o., praha array - 2418 metformin-hydrochlorid - potahovaná tableta - 1000mg - metformin
metoprolol aurovitas 100mg potahovaná tableta
aurovitas, spol. s r.o., praha array - 4634 metoprolol-tartarÁt - potahovaná tableta - 100mg - metoprolol
metoprolol aurovitas 50mg potahovaná tableta
aurovitas, spol. s r.o., praha array - 4634 metoprolol-tartarÁt - potahovaná tableta - 50mg - metoprolol
nolibeta 5mg tableta
krka, d.d., novo mesto, novo mesto array - 12056 nebivolol-hydrochlorid - tableta - 5mg - nebivolol
dynepo
shire pharmaceutical contracts limited - epoetin delta - kidney failure, chronic; anemia - antianemické přípravky - dynepo je indikován pro léčbu symptomatickou anémií spojenou s chronickou renální selhání (crf) u dospělých pacientů. může být použita u pacientů na dialýze a u pacientů, kteří nejsou na dialýze.
flebogamma dif (previously flebogammadif)
instituto grifols s.a. - normální lidský imunoglobulin - mucocutaneous lymph node syndrome; guillain-barre syndrome; bone marrow transplantation; purpura, thrombocytopenic, idiopathic; immunologic deficiency syndromes - imunitní séra a imunoglobuliny, - replacement therapy in adults, children and adolescents (0-18 years) in: , primary immunodeficiency syndromes with impaired antibody production;, hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic luekaemia, in whom prophylactic antibiotics have failed;, hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who failed to respond to pneumococcal immunisation;, hypogammaglobulinaemia in patients after allogenic haematopoietic-stem-cell transplantation (hsct);, congenital aids with recurrent bacterial infections. , immunomodulation in adults, children and adolescents (0-18 years) in: , primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;, guillain barré syndrome;, kawasaki disease.